Surveillance imaging in pediatric Hodgkin Lymphoma

Children with Hodgkin Lymphoma (HL) routinely undergo surveillance computed tomography (CT) imaging for up to 5 years post-therapy (Rx), resulting in increased cost and radiation exposure without clear benefit. A number of recent studies have demonstrated that routine surveillance imaging, by CT, positron emission tomography (PET)/CT, as well as other imaging techniques, may be over-utilized for routine surveillance of patients with Hodgkin Lymphoma, and-in addition to contributing to increased cost and radiation exposure-show no clear survival benefit. The purpose of this review is to summarize recent data evaluating routine surveillance imaging and its role in detecting disease relapse in patients with Hodgkin Lymphoma.